Managed care and the quality of substance abuse treatment

Journal of Mental Health Policy and Economics

Volumn 5, Issue 4, 2002, Pages 163-174

  Shepard, Donald S ^a   Daley, Marilyn ^a   Ritter, Grant A ^a   Hodgkin, Dominic ^a   Beinecke, Richard H ^b  

^a BRANDEIS UNIVERSITY   (United States)

^b SUFFOLK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COCAINE; DIAMORPHINE;

ADULT; AGE; ALCOHOLISM; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; COST CONTROL; DISABILITY; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEROIN DEPENDENCE; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAID; MEDICAL RESEARCH; MENTAL HEALTH SERVICE; OUTCOMES RESEARCH; PATIENT CARE; PROFIT; QUALITY CONTROL; RACE DIFFERENCE; RISK MANAGEMENT; SELF REPORT; SEX DIFFERENCE; SUBSTANCE ABUSE; TIME SERIES ANALYSIS; UNITED STATES; URINALYSIS;

ADULT; CONTINUITY OF PATIENT CARE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HUMANS; MALE; MANAGED CARE PROGRAMS; MASSACHUSETTS; MEDICAID; MENTAL HEALTH SERVICES; MIDDLE AGED; PATIENT ADMISSION; PUBLIC SECTOR; QUALITY OF HEALTH CARE; SUBSTANCE-RELATED DISORDERS;

EID: 0038784184     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Robinson GK. Managed Care Tracking Systems: State Profiles on Public Sector Managed Behavioral Health Care and Other Reforms. Rockville, Md: US Dept of Health and Human Services, Substance Abuse and Mental Health Services Administration; 1998. Publication SMA 99-3289.
2. Frank RG, McGuire TG, Notman EH, Woodward RM. Developments in Medicaid managed behavioral health care. In: Mental Health in the United States. Rockville, MD: US Dept of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services; 1996.
3. Sabin JE, Daniels N. Public-sector managed behavioral health care: II. Contracting for medicaid services - the Massachusetts experience. Psychiatr Serv 1999; 50(1): 39-41.
4. Callahan JJ, Shepard DS, Beinecke RH, Larson MJ, Cavanaugh, D. Mental health/substance abuse treatment in managed care: The Massachusetts Medicaid experience. Health Aff 1995; 143(3):173-184.
5. Counihan CW, Nelson D, Pattullo R. A Medicaid mental health carve-out program: the Massachusetts experience. Manag Care Q 1996; 4(3): 85-92.
6. Dickey B, Norton EC, Azeni H, Fisher W, Altaffer F. Managing the care of schizophrenia: lessons from a four year Massachusetts Medicaid study. Arch Gen Psychiatry 1996; 53(10): 945-52.
7. Dickey B, Norton, EC, Normand S, Azeni H, Fisher W, Altaffer F. Massachusetts Medicaid managed care reform: treatment for the psychiatrically disabled. Advances in Health Economics and Health Research 1995; 15: 99-116.
8. Frank RG, McGuire TG. 1997. Savings from a Medicaid carve-out for mental health and substance abuse in Massachusetts. Psychiatr Serv 1997; 48(9): 1147-52.
9. Bloom JR, Hu TW, Wallace N. Mental health costs and outcomes under alternative capitation systems in Colorado: early results. J Ment Health Policy Econ 1998; 1:3-13.
10. Cuffel B, Regier D. The relationship between treatment access and spending in a managed behavioral health organization. Psychiatr Serv 2001; 52(7):949-52.
11. Deck DD, McFarland BH, Titus M, Laws E, Gabriel RM. Access to substance abuse treatment under the Oregon health plan. JAMA 2000; 284(16):2093-99.
12. Grazier KL, Eselius LL. 1999. Mental health carve-outs: effects and implications. Med Care Res Rev 1999; 56(Supplement 2):37-59,
13. Grazier KL, Eselius LL, Hu TW, Shore KK, G'Sell WA. Effects of a mental health carve-out on use, costs and payers: a four-year study. J Behav Health Serv Res 1999; 26(4):381-89.
14. Huskamp, H. How a managed behavioral health carve-out plan affected spending for episodes of treatment. Psychiatr Serv 1998; 49:147-61.
15. Ma CA, McGuire TG. Costs and incentives in a behavioral health carve-out. Health Aff 1998; 17(2):53-69.
16. Merrick, EL. Treatment of major depression before and after the implementation of a behavioral health carve-out plan. Psychiatr Serv 1998; 49:1563-67.
17. Steenrod S, Brisson A, McCarty D, Hodgkin D. Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. In: Galanter M, ed. Recent Developments in Alcoholism, Volume 15: Services Research in the Era of Managed Care. New York, NY: Kluwer Academic/Plenum Publishers; 2001
18. Stein B, Reardon E, Sturm R. Substance abuse service utilization under managed care: HMOs versus carve-out plans. J Behav Health Serv Res 1999 26(4):451-456.
19. Argeriou M, McCarty D, Dilonardo J, Denmead G, Ettner S, Normand SL, Tompkins E, Bouchery E, Harwood H, Pugh-YI R, Tepper F. State Substance Abuse/Mental Health Managed Care Evaluation: Final Contract Report Rockville, Md: US Dept of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment/Center for Mental Health Services 2001. CSAT/CMHS Contract #270-96-0002
20. Sturm R. Tracking changes in behavioral health: how have carve-outs changed care? J Behav Health Serv Res 1999; 26(4): 360-371.
21. Hellinger FJ. The effect of managed care on quality: a review of recent evidence. Arch Intern Med 1998; 158: 833-41.
22. Vogelsang I. Economic aspects of mental health carve-outs. J Ment Health Policy Econ 1999; 2(1): 29-41.
23. Galanter M, Keller DS, Dermatis H, Egelko S. The impact of managed care on substance abuse treatment: a problem in need of solution (A report of the American Society of Addiction Medicine). In: Galanter M, ed. Recent Developments in Alcoholism, Volume 15: Services Research in the Era of Managed Care. New York, NY: Kluwer Academic/Plenum Publishers; 2001.
24. Rohrer JE, Rowland BM, Westermann J, Knott J, Zwick J. Managed care for substance abuse treatment: impact in Iowa. Adm Policy Ment Health 1999 Jul 26(6):429-33.
25. Goldman W McCulloch J, Sturm R. Costs and use of mental health services before and after managed care. Health Aff 1998; 17(2):40-52.
26. Shepard DS, Daley M, Ritter GA, Hodgkin D. Effects of a state-wide carve-out on spending and access to substance abuse treatment in Massachusetts, 1992 to 1996. Health Serv Res 2002; 36(6) Part II: 32-44.
27. Chang CF, Kiser LJ, Bailey, JE, Martins M, Gibson WC, Schaberg KA, Mirvis DM, Applegate WB. Tennessee's failed managed care program for mental health and substance abuse services. JAMA 1998; 279(11):864-69.
28. Asher M, Friedman N, Lysioneck C, Peters C. Evaluation of the implementation of Pennsylvania's Act 152: The quantitative findings Villanova (PA): Human Organization Science Institute, Villanova University; 1995.
29. Ellis RP. Drug abuse treatment patterns before and after managed care Third Annual Advisory Committee on Managed Care Meeting. Washington, DC: April 27, 1992.
30. Brisson AS. Changes in a managed behavioral health care carve-out and the impact on substance abuse services [dissertation]. Waltham MA: Brandeis Univ.; 1999.
31. Barnett PG, Swindle RW. Cost-effectiveness of inpatient substance abuse treatment. Health Serv Res 1997; 32(5):615-629.
32. Thakur NM, Hoff RA, Druss B, Catalanotto J. Using recidivism rates as a quality indicator for substance abuse treatment programs. Psychiatr Serv 1998; 49(10):1347-1350.
33. Daley M, Argeriou M, McCarty D, Shepard DS, Callahan JJ, Williams CN. The impact of substance abuse treatment on birth weight and health care expenditures. J Psychoactive Drugs 2001; 31(1):57-66.
34. Renz EA, Chung R, Fillman TO, Mee-Lee D, Sayama M. The effect of managed care on the treatment outcome of substance use disorders. Gen Hosp Psychiatry 1995; 17:287-292.
35. Principles of Drug Addictions Treatment: A Research Based Guide Rockville (MD): US Department of Health and Human Services, Public Health Service, National Institute on Drug Abuse; 1999. NIH Publ No.: 99-4180.
36. Miller NS, Ninonuevo F, Hoffmann NG, Astrachan BM. Prediction of treatment outcomes: lifetime depression versus the continuum of care. Am J Addict 1999; 3:243-53.
37. McKay, JR. The role of continuing care in outpatient alcohol treatment programs. In: Galanter M, Ed. Recent Developments in Alcoholism, 15: Services Research in the Era of Managed Care. New York, NY: Kluwer Academic/Plenum Publishers 2001
38. Rapp RC, Siegal HA, Li L, Saha P. Predicting post-primary treatment services and drug use outcome: A multivariate analysis. Am J Drug Alcohol Abuse 1998; 24(4):603-615.
39. Mattick RP, Hall W. Are detoxification programmes effective? Lancet 1996; 347: 97-100.
40. Gerstein DR, Harwood HJ, Suter N, Maloy K. Evaluating Recovery Services: The California Drug and Alcohol Treatment Assessment (CALDATA). Sacramento, CA: California Department of Alcohol and Drug Problems: 1994.
41. French MT, Salome J, Krupski A, McKay JR, Donovan DM, McLellan AT, Durell J. Benefit-cost analysis of residential and outpatient addiction in the State of Washington. Eval Rev 2000; 24(6):609-634.
42. Manning WG, Chuan-Fen L, Stoner TJ, Gray DZ, et al. Outcomes for Medicaid beneficiaries with schizophrenia under a prepaid mental health carve-out. J Behav Health Serv Res 1999; 26(4):442-450.
43. Ware JE, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in four year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems: results from the medical outcomes study. JAMA 1996; 276(13):1039-1047.
44. Alterman AI, Randall M, McLellan AT. Comparison of outcomes by gender and for fee-for-service versus managed care: a study of nine community programs. J Subst Abuse Treat 2000; 19:127-134.
45. SAS/STAT Software. Version 8. Cary, NC: SAS Institute, Inc.
46. US Dept of Labor, Bureau of Labor Statistics. Consumer Price Index: All Urban Consumers, Boston Area, Medical Services. Washington DC: US Dept of Labor; 2002.
47. Hoffman ED, Klees BS, Curtis CA. Overview of the Medicare and Medicaid programs. Health Care Financ Rev Stat Suppl. 2000; 1-348.
48. Commonwealth of Massachusetts, Department of Public Health, Bureau of Substance Abuse Services. Drug Use Trends: Greater Boston 1992-1997. Boston (MA): Health and Addictions Research, Inc.: 1998.
49. Beinecke RH, Callahan JJ, Shepard DS, Cavanaugh DA, Larson MJ. The Massachusetts Mental Health/Substance Abuse managed care program: the providers' view. Adm Policy Ment Health 1996; 23(5): 379-391.
50. Beinecke RH, Goodman M, Lockhart A. The impact of managed care on Massachusetts' mental health and substance abuse providers. Adm Soc Work 1997; 21(2):41-53.
51. Beinecke RH, Shepard DS, Goodman M. Assessment of the Massachusetts managed mental health/substance abuse program: year three. Adm Policy Ment Health 1997; 24(5):205-220.
52. Beinecke RH, Perlman SB. The impact of the Massachusetts managed mental health/substance abuse program on outpatient mental health clinics. Comm Ment Health J 1997; 33(5):377-385.
53. Beinecke RH, Lockhart A. A provider assessment of the Massachusetts Medicaid managed behavioral health care program: Year four. Adm Ment Health 1998; 25(4):411-426.
54. Beinecke RH, Keane RJ, Symanzick M, Casey D. The Massachusetts behavioral health program year five: transition to a new managed care organization. Adm Policy Ment Health 1999; 26(5):313-327.
55. Shepard DS, Beinecke RH, Reif S, Cavanaugh DA. Effect of a managed care carve-out on substance abuse treatment in Massachusetts: the providers' perspective. Alcohol Treatment Quarterly 2002; in press.
56. Humphreys K, Weingardt KR. Assessing re-admission to substance abuse treatment as an indicator of outcome and program performance. Psychiatr Serv 2000; 51(12):1568-9.
57. Beinecke RH, Shepard DS, Sousa D, Leung M. Evaluation of the Massachusetts behavioral health program: Year 8. Adm Policy Ment Health 2002; forthcoming.